Development and Initial Evaluation of a Multifaceted Intervention to Improve Mental Health and Quality of Life Among Pro

  • PDF / 319,734 Bytes
  • 14 Pages / 439.37 x 666.142 pts Page_size
  • 53 Downloads / 200 Views

DOWNLOAD

REPORT


Development and Initial Evaluation of a Multifaceted Intervention to Improve Mental Health and Quality of Life Among Prostate Cancer Survivors Gabriela Ilie 1,2,3,4 & Ross Mason 2 & David Bell 2 & Greg Bailly 2 & Ricardo A. Rendon 2 & Robert Mann 5,6 & Joseph G. Lawen 2 & David Bowes 4 & Derek Wilke 4 & Nikhilesh Patil 4 & Robert D. H. Rutledge 4

# Springer Science+Business Media, LLC, part of Springer Nature 2019

Abstract Mental health issues affect a third of prostate cancer (PCa) survivors. Here, we describe the development and preliminary evaluation of a unique multifaceted intervention, the Prostate Cancer–Patient Empowerment Program (PC-PEP), designed to improve mental health and quality of life among survivors. The 28-day pilot PC-PEP Intervention was developed following the engagement of patients, survivors, caregivers and health care professionals In identifying survivorship needs and well-being resources for improved mental health. The pilot intervention was implemented with a group of 30 PCa survivors in Halifax, Canada. Measures collected over the 28-day program included psychological distress and physical health indicators, as well as program compliance. Participation in PC-PEP resulted in significant improvement in measures of mental and physical health over the 28-day program. Very good to excellent compliance with all five components of PC-PEP was observed. This evaluation provides strong initial support for a multifaceted program to improve mental health outcomes in prostate cancer survivors. Keywords Prostate cancer . Survivorship . Mental health . Fitness . Patient education and empowerment program Prostate cancer is the most common cancer malignancy affecting Canadian men with more than 21,300 new cases each year (Canadian Cancer Statistics 2017). Prostate cancer accounts for about one-fifth (21%) of all new cancer cases in men and remains the third leading cause of cancer death (behind lung and colorectal cancers) in men in Canada (Ellison 2016). By 2036, because of the aging trend in our population and an expected doubling in the number of adults over 65, the incidence of prostate cancer cases is also expected to double (Statistics Canada 2010). Advances in detection, diagnosis, and effective active forms of treatment have

* Gabriela Ilie [email protected] Extended author information available on the last page of the article

International Journal of Mental Health and Addiction

improved our ability to customize recommendations based on the stage of the disease, prognosis, and patient preferences (Litwin and Tan 2017) leading to defining PCa as a longterm condition. Survival rates for early-stage prostate cancer 10 years after diagnosis are as high as 99%, regardless of whether men undergo surgery, radiation, or are actively monitored (Hamdy et al. 2016), but are often accompanied by compounding short- and long-term side effects (e.g., especially issues related to urinary, bowel, sexual function) (Donovan et al. 2016). Less focus, however, has been placed on trying to understand the men